The Wearable Veterinary Ultrasound Scanner segmentation by application distinguishes three primary use‑cases that together drive market revenue. Diagnostic scanners, accounting for roughly 45 % of sales, are deployed in routine examinations to detect musculoskeletal injuries, abdominal anomalies, and cardiac conditions in companion and livestock animals. Their high adoption stems from the need for rapid, non‑invasive assessments in field settings, reducing reliance on stationary equipment. Therapeutic monitoring devices represent about 35 % of the market and are integrated into treatment protocols for guided drug delivery, physiotherapy, and postoperative care, where continuous imaging informs dosage adjustments and recovery progress. Finally, research applications, comprising the remaining 20 %, support academic and pharmaceutical studies that require longitudinal data capture across diverse animal models. Each application contributes proportionally to the overall market size by reflecting distinct purchase drivers—clinical workflow efficiency, treatment outcome optimization, and scientific data acquisition—thereby shaping product development priorities and pricing strategies.